Biofrontera, Inc. (BFRI)
0.7891
+0.01
(+1.04%)
USD |
NASDAQ |
Oct 23, 16:00
0.7801
-0.01
(-1.14%)
After-Hours: 20:00
Biofrontera Enterprise Value : 14.05M for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 14.05M |
| October 22, 2026 | 13.93M |
| October 21, 2026 | 14.20M |
| October 20, 2026 | 14.26M |
| October 19, 2026 | 14.28M |
| October 16, 2026 | 14.51M |
| October 15, 2026 | 14.87M |
| October 14, 2026 | 14.63M |
| October 13, 2026 | 15.51M |
| October 12, 2026 | 15.98M |
| October 09, 2026 | 16.62M |
| October 08, 2026 | 15.89M |
| October 07, 2026 | 16.13M |
| October 06, 2026 | 16.08M |
| October 05, 2026 | 15.49M |
| October 02, 2026 | 17.26M |
| October 01, 2026 | 17.61M |
| September 30, 2026 | 18.18M |
| September 29, 2026 | 18.32M |
| September 28, 2026 | 18.89M |
| September 25, 2026 | 19.60M |
| September 24, 2026 | 19.88M |
| September 23, 2026 | 19.17M |
| September 22, 2026 | 19.46M |
| September 21, 2026 | 19.32M |
| Date | Value |
|---|---|
| September 18, 2026 | 21.59M |
| September 17, 2026 | 20.45M |
| September 16, 2026 | 20.03M |
| September 15, 2026 | 19.74M |
| September 14, 2026 | 22.16M |
| September 11, 2026 | 24.86M |
| September 10, 2026 | 23.58M |
| September 09, 2026 | 24.71M |
| September 08, 2026 | 25.00M |
| September 04, 2026 | 25.71M |
| September 03, 2026 | 24.29M |
| September 02, 2026 | 24.43M |
| September 01, 2026 | 24.64M |
| August 31, 2026 | 24.57M |
| August 28, 2026 | 25.42M |
| August 27, 2026 | 24.00M |
| August 26, 2026 | 24.57M |
| August 25, 2026 | 24.29M |
| August 24, 2026 | 23.58M |
| August 21, 2026 | 23.86M |
| August 20, 2026 | 23.86M |
| August 19, 2026 | 23.01M |
| August 18, 2026 | 23.29M |
| August 17, 2026 | 22.02M |
| August 14, 2026 | 21.30M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| ANI Pharmaceuticals, Inc. | 1.903B |
| Corcept Therapeutics, Inc. | 8.967B |
| Veru, Inc. | 15.08M |
| Johnson & Johnson | 662.44B |
| Eli Lilly & Co. | 1.245T |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.604M |
| Revenue (Quarterly) | 12.00M |
| Total Expenses (Quarterly) | 12.61M |
| EPS Diluted (Quarterly) | -0.0467 |
| Gross Profit Margin (Quarterly) | 91.59% |
| Profit Margin (Quarterly) | -5.03% |
| Earnings Yield | -74.29% |
| Normalized Earnings Yield | -35.80 |